as UUI. We assessed whether the quantification of urodynamic DO can improve the prediction of post-operative UUI following the HoLEP in patients with benign prostatic hyperplasia.
METHODS: We prospectively measured the filling volume at DO (Vol_DO), detrusor pressure at DO (P det DO), and presence or absence of DO incontinence, in addition to the ICS recommendations for urodynamic study (UDS) in 105 patients who underwent HoLEP between May 2010 and September 2015.
RESULTS: Mean age (AESD) and prostate volume were 71.1 (AE7.0) years and 63.7 (AE24.2) mL. Of the 105 patients, 10 (9.5%) patients experienced the UUI at post-operative 3 months. The UUI-positive group demonstrated higher international prostate symptom score (IPSS)-storage (11.4 vs. 7.5, p¼0.004) than the UUI-negative group. However, other parameters such as age, prostate size, preoperative uroflometry findings, IPSS-emptying, and IPSS-QoL were not significantly different between two groups (p range, 0.062-0.797). On UDS findings, UUI-positive group showed higher P det DO than UUI-negative group (100.4 vs. 54.7 cmH 2 O, p¼0.008). However, rates of DO presence and DO_vol were not significantly different between two groups (p-value, 0.423 and 0.788). DO incontinence is more frequent in UUI-positive group than in UUI-negative group, but failed to reach the statistical significance (80.0 vs. 52.6%, p¼0.098). Spline curve analysis results suggested the optimal cut-off value of P det DO for increased risk of UUI as 108.0 cmH 2 O (Figure) . Our multivariate analysis revealed that pre-operative IPSS-storage (OR¼1.696, p¼0.036) and P det DO (!108.0 cmH2O; OR¼15.546, p¼0.044) were independent predictive factors for UUI after HoLEP.
CONCLUSIONS: Quantification of urodynamic DO improved the prediction of UUI after HoLEP Source of Funding: None
MP27-04 GIVING UNDERACTIVE BLADDERS A SECOND CHANCE: HOLMIUM LASER ENUCLEATION OF THE PROSTATE FOR MANAGEMENT OF LOWER URINARY TRACT SYMPTOMS IN PATIENTS WITH DETRUSOR UNDERACTIVITY.
Garrett Smith*, Dongliang Wang, Jessica E. Paonessa, Syracuse, NY INTRODUCTION AND OBJECTIVES: Lower urinary tract symptoms (LUTS) in men are classically attributed to bladder outlet obstruction (BOO). However, LUTS may also exist in the presence of detrusor underactivity (DU). Evaluation of the voiding phase in patients with BOO demonstrates high bladder pressures and low flow rates. In contrast, low bladder pressures and low flow rates are characteristic of patients with DU. Holmium laser enucleation of the prostate (HoLEP) has been shown to be a safe, durable and effective surgical treatment for BOO secondary to benign prostatic enlargement (BPE) in prostates of any size. In our early experience, we have identified a population of patients with DU and BPE who have benefitted from HoLEP. We compared patients with BOO to those with DU to determine if outcomes after HoLEP are comparable.
METHODS: Our HoLEP database was retrospectively reviewed, identifying 84 patients with preoperative (preop) urodynamic studies (UDS) who underwent HoLEP with or without bladder neck incision (+/-BNI). Of these patients, 24 had UDS consistent with DU; defined as max flow rate (Qmax) < 15 ml per second and detrusor pressure (Pdet) < 40 cm water. The remaining 60 patients had BOO (Qmax < 15 and Pdet ! 40). International Prostate Symptom Score and Sexual Health Inventory for Men questionnaires were administered preop and at each postoperative (postop) visit. All surgeries were performed by a single surgeon, supervising residents, from December 2014 to September 2016.
RESULTS: There were no differences (p > 0.05) in patient demographics, catheter dependence, preop questionnaires and incontinence, enucleation/morcellation time, tissue volume removed and length of hospital stay between the two groups. Patients with DU had higher preop post void residual (PVR) (p ¼ 0.017) and lower Qmax (p ¼ 0.007). There were no differences in postop questionnaires and incontinence at 6 weeks, 6 months (mo) and 12 mo. PVRs were higher in DU patients at 6 weeks (p ¼ 0.012), but not at 6 and 12 mos. All patients were able to void after HoLEP. One patient with DU was self catheterizing once nightly at 6 mo follow up.
CONCLUSIONS: The standard treatment for patients with DU and urinary retention is catheterization (clean intermittent or chronic indwelling). Typically, these patients are not offered surgery. For patients who can Valsalva and stand to void, HoLEP +/-BNI may improve quality of life and allow them to be catheter free. These findings may also support expanding the indications for HoLEP.
Source of Funding: None.
MP27-05 PROSPECTIVE STUDY COMPARING SAFETY AND EFFICACY OF HOLEP FOR RECURRENT BPH AFTER INITIAL TURP
Hemendra Shah*, Rashmi Shah, Mumbai, India INTRODUCTION AND OBJECTIVES: To prospectively evaluate safety and efficacy of Holmium laser enucleation of prostate (HoLEP) in patients with symptomatic prostate recurrence after prior transurethral resection of prostate (TURP). We also studied indication of secondary prostatectomy after prior TURP.
METHODS: We prospectively evaluated 43 patients with past history of TURP who underwent HoLEP between June 2003 & May 2016 (study group). The technique of enucleation was modified based on the morphology of recurrent adenoma. 100 W holmium laser machine with 550 micron laser fiber was used. Patient's demographics, intra and postoperative data was entered in IBM SPSS Statistics 24 software and compared with 43 randomly selected patients who underwent HoLEP without prior TURP at our institute (control group). Each control group patient was the one who underwent HoLEP immediately after the study group patient in the sequence of HoLEP patients at our institute.
RESULTS: Patients demographics are shown in table 1. Study group patients predominantly presented with gross recurrent hematuria (58.1 %; 25/43) and had less AUA symptom score and better uroflowmetry rates than control group. The average interval between past TURP and HoLEP was 4.22 years (range-1 month to 16 years). Table 2 & 3 reveals that the intraoperative parameters and postoperative outcome were comparable in both groups. Vol. 197, No. 4S, Supplement, Saturday, May 13, 2017 THE JOURNAL OF UROLOGY â e329
